← Back to Search

Behavioural Intervention

Adapt2Quit Motivational System for Quitting Smoking (A2Q Trial)

N/A
Recruiting
Led By Rajani Sadasivam, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English-speaking
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months post-randomization
Awards & highlights

A2Q Trial Summary

This trial will test whether a computer program that sends motivational messages can help people quit smoking, compared to just receiving texts to use a quitline.

Who is the study for?
This trial is for English-speaking adults who smoke, have had at least two clinical visits in the past year, and are socioeconomically disadvantaged. They must own a texting-enabled cell phone. Pregnant women, prisoners, those unable to consent, minors, and previous pilot study participants cannot join.Check my eligibility
What is being tested?
The Adapt2Quit program is being tested against a control that only facilitates quitline use via text messages. The program sends motivational texts tailored to help users quit smoking based on their feedback on message effectiveness.See study design
What are the potential side effects?
Since this trial involves motivational messaging rather than medication or medical procedures, there are no direct physical side effects associated with participation.

A2Q Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I speak English.

A2Q Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months post-randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemical Carbon Monoxide (CO) Verification of Tobacco Cessation
Self-Reported Participant Tobacco Cessation Rate (quit rate)
Secondary outcome measures
Time to First Quit Attempt

A2Q Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adapt2QuitExperimental Treatment1 Intervention
These participants will receive Adapt2Quit motivational messaging and quitline facilitation messaging for 6 months.
Group II: ControlActive Control1 Intervention
These participants will receive quitline facilitation-only messaging for 6 months.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityOTHER
2,260 Previous Clinical Trials
14,819,925 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,923,891 Total Patients Enrolled
Baystate HealthOTHER
6 Previous Clinical Trials
52,375 Total Patients Enrolled

Media Library

Adapt2Quit (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04720625 — N/A
Tobacco Smoking Research Study Groups: Adapt2Quit, Control
Tobacco Smoking Clinical Trial 2023: Adapt2Quit Highlights & Side Effects. Trial Name: NCT04720625 — N/A
Adapt2Quit (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04720625 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction for enrollment in this research program?

"This medical trial has set the minimum age of enrollment at 18 and the maximum age of participation as 99 years old."

Answered by AI

Are any new participants still signing up for this research project?

"According to information available on clinicaltrials.gov, this research endeavor is currently seeking additional participants. The trial was initially advertised on the 28th of June 2021 and most recently revised on the 5th of February 2022."

Answered by AI

How many enrollees is this clinical trial accommodating?

"Affirmative. Clinicaltrials.gov states that this medical experiment, which was initially posted on June 28th 2021, is still in need of participants. 750 people have to be recruited from 3 distinct locations."

Answered by AI

What are the eligibility requirements for participating in this clinical investigation?

"This trial is recruiting 750 people who smoke tobacco and have an age range between 18-99. The applicants need to meet the following criteria: disadvantaged financially (unemployed, low wage earning, no coverage or insufficient insurance, low level of education), smoking habitually in current times, capable of conversing fluently in English language, actively engaging with medical caretaker(s) within a year's time frame and must possess a cellular phone enabled for text messaging."

Answered by AI

Who else is applying?

What state do they live in?
New York
Connecticut
How old are they?
18 - 65
What site did they apply to?
University of Massachusetts Medical School
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I would like to quit smoking cigarettes and I saw your trial listed on clinic trials.gov and it sounds really interesting.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers
Rajani Sadasivam 2021. "Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04720625.
~96 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top